Presepsin在脓毒症诊断中的意义(3)
[9] Shirakawa K， Naitou K，Hiros J，et al. The new sepsis marker， sCD14-ST， induction mechanism in the rabbit sepsis models[J]. Crit Care，2010，14(suppl 2)：19.
[10] Nakamura M， TTakeuchi T，Naio K， et al.Early elevaion of plasma soluble CD14 subtype， a novel biomarker for sepsis，in a rabbit cecal ligation and puncture model[J].Critical Care ，2008，12(suppl 2)：194.
[11] Leli C， Ferranti M， Marrano U， et al.Diagnostic accuracy of presepsin (sCD14-ST)and procalcitonin for prediction of bacteremia and bacterial DNAemia in patients with suspected sepsis[J].J Med Microbiol，2016，65(8)：713.
[12] Shozushima T， TakahashiG， Matsumoto N， et al. Usefulness of presepsin (sCD14-ST) messurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome[J].J Infect Chemother， 2011， 17(6)：764-769.
[13] Lin J， Sun H， Li J，et al. Role of Presepsin for the Assessment of Acute Cholangitis Severity[J].Clin Lab. 2016， 62(4)： 679-687.
[14] Sato R，Suzuki Y，Sato M，et al.Serum levels of presepsin reflects the APACHE II and SOFA scores inpatients with sepsis[J].Crit Carek，2013，17(Suppl 2)：48.
[15] Masson S，Caironi P，Spanuth E，et al.Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis ：data from the Albumin Italian Outcome Sepsis trial[J].Crit Care，2014，18(1)：R6.
[16] Caglar FNT，Isiksacan N，Biyik I，et al.Presepsin(sCD14-ST);could it be a novel marker for the diagnosis of ST elevation myocardial infarction[J].Arch Med Sci Atheroscler Dis，2017，2(1)：e3-e8.
[17] Chenevier-Gobeaux C，Trabattoni E，Roelens M，et al.Presepsin(sCD14-ST)in emergency department：the need for adapted threshold values[J].Clin Chim Acta，2014，427(1)：34-36.
[18] Nanno S，Koh H，Katayama T，et al.Plasma Levels of Presepsin(Soluble CD14-subtype)as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancics[J]. Intern Med， 2016， 55(16)： 2173-2184., http://www.100md.com(周磊磊 姚丽萍)
[10] Nakamura M， TTakeuchi T，Naio K， et al.Early elevaion of plasma soluble CD14 subtype， a novel biomarker for sepsis，in a rabbit cecal ligation and puncture model[J].Critical Care ，2008，12(suppl 2)：194.
[11] Leli C， Ferranti M， Marrano U， et al.Diagnostic accuracy of presepsin (sCD14-ST)and procalcitonin for prediction of bacteremia and bacterial DNAemia in patients with suspected sepsis[J].J Med Microbiol，2016，65(8)：713.
[12] Shozushima T， TakahashiG， Matsumoto N， et al. Usefulness of presepsin (sCD14-ST) messurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome[J].J Infect Chemother， 2011， 17(6)：764-769.
[13] Lin J， Sun H， Li J，et al. Role of Presepsin for the Assessment of Acute Cholangitis Severity[J].Clin Lab. 2016， 62(4)： 679-687.
[14] Sato R，Suzuki Y，Sato M，et al.Serum levels of presepsin reflects the APACHE II and SOFA scores inpatients with sepsis[J].Crit Carek，2013，17(Suppl 2)：48.
[15] Masson S，Caironi P，Spanuth E，et al.Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis ：data from the Albumin Italian Outcome Sepsis trial[J].Crit Care，2014，18(1)：R6.
[16] Caglar FNT，Isiksacan N，Biyik I，et al.Presepsin(sCD14-ST);could it be a novel marker for the diagnosis of ST elevation myocardial infarction[J].Arch Med Sci Atheroscler Dis，2017，2(1)：e3-e8.
[17] Chenevier-Gobeaux C，Trabattoni E，Roelens M，et al.Presepsin(sCD14-ST)in emergency department：the need for adapted threshold values[J].Clin Chim Acta，2014，427(1)：34-36.
[18] Nanno S，Koh H，Katayama T，et al.Plasma Levels of Presepsin(Soluble CD14-subtype)as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancics[J]. Intern Med， 2016， 55(16)： 2173-2184., http://www.100md.com(周磊磊 姚丽萍)